Education
About Us
Working with TipRanks
Follow Us
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
ASX:HPC
HPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.02
Previous CloseN/A
Volume65.65K
Average Volume (3M)1.21M
Market Cap
AU$4.31M
Enterprise ValueAU$572.13K
Total Cash (Recent Filing)AU$2.11M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.78
Next Earnings
Mar 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding430,800,930
10 Day Avg. Volume3,315,133
30 Day Avg. Volume1,207,806
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.51
Price to Sales (P/S)0.44
P/FCF Ratio-0.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hydration Pharmaceuticals Co. Ltd. News
HPC FAQ
What was Hydration Pharmaceuticals Co. Ltd.’s price range in the past 12 months?
Hydration Pharmaceuticals Co. Ltd. lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Hydration Pharmaceuticals Co. Ltd.’s market cap?
Hydration Pharmaceuticals Co. Ltd.’s market cap is AU$4.31M.
When is Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date?
Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date is Mar 02, 2026 which is in 143 days.
How were Hydration Pharmaceuticals Co. Ltd.’s earnings last quarter?
Hydration Pharmaceuticals Co. Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.007.
Is Hydration Pharmaceuticals Co. Ltd. overvalued?
According to Wall Street analysts Hydration Pharmaceuticals Co. Ltd.’s price is currently Overvalued.
Does Hydration Pharmaceuticals Co. Ltd. pay dividends?
Hydration Pharmaceuticals Co. Ltd. does not currently pay dividends.
What is Hydration Pharmaceuticals Co. Ltd.’s EPS estimate?
Hydration Pharmaceuticals Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hydration Pharmaceuticals Co. Ltd. have?
Hydration Pharmaceuticals Co. Ltd. has 430,800,930 shares outstanding.
What happened to Hydration Pharmaceuticals Co. Ltd.’s price movement after its last earnings report?
Hydration Pharmaceuticals Co. Ltd. reported an EPS of -AU$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hydration Pharmaceuticals Co. Ltd.?
Currently, no hedge funds are holding shares in AU:HPC
Hydration Pharmaceuticals Co. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:HPC Sentiment 100%
Sector Average 66%
Sector Average 66%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
―
20 days / 200 days
Momentum
-47.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-28.90%
Trailing 12-Months
Company Description
Hydration Pharmaceuticals Co. Ltd.
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The company was founded in 2001 and is headquartered in San Diego, California.
Technical Analysis
Options Prices
Currently, No data available
---